ArticleEnvironment & health (Washington, D.C.)2024
Association of Multiple Urinary Phthalates Metabolites with Diabetes Risk in Elderly Population.
Article in Environment & health (Washington, D.C.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Developmental Mono(2-ethylhexyl) Phthalate Exposure Impairs Offspring Neurobehavior through Suppression of CYP450 Transcriptional Pathways.Environment & health (Washington, D.C.) · 2026Article
- Exposure Levels and Health Risks of Phthalate Alternatives: A Urinary Metabolite Study.Environment & health (Washington, D.C.) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As a common environmental endocrine disruptor, phthalate exposure could affect the diabetes risk. However, it remains unclear whether phthalate exposure in the elderly population alters diabetes risk. We conducted a cross-sectional survey to explore the effect of urinary phthalate metabolites on diabetes in the elderly. We conducted a health survey of 200 elderly in northeastern China and measured urinary concentrations of 64 phthalate metabolites. We next evaluated the association between major phthalates and phthalate mixtures and diabetes in the elderly. The least absolute shrinkage and selection operator (LASSO) regression screened for mono (3-carboxypropyl) phthalate (MCPP), monoethyl phthalate (MEP), and mono (2-ethyl-5-hydroxyhexyl) phthalate (MEHHP) as important predictors for diabetes. Weighted quantile sum (WQS) regression and Bayesian Kernel Machine regression (BKMR) models consistently found MEHHP (Weights = 51.9%, PIP = 0.97) to have the greatest effect on diabetes risk in the elderly. Furthermore, MEHHP was associated with an increased risk of diabetes in the multipollutant logistic regression model (OR = 2.148, 95% CI: 1.255 to 3.677). The overall effect of coexposure to MCPP, MEHHP, and MEP on the risk of diabetes in elderly population was significant and positive. In summary, we found that increased urinary MEHHP levels could increase the risk of diabetes in the elderly population. Co-exposure to MCPP, MEHHP and MEP may increase the risk of diabetes.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.